CoChat

Big data in IBD: big progress for clinical practice

Open access

The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.

Abstract

IBD is a complex multifactorial inflammatory disease of the gut driven by extrinsic and intrinsic factors, including host genetics, the immune system, environmental factors and the gut microbiome. Technological advancements such as next-generation sequencing, high-throughput omics data generation and molecular networks have catalysed IBD research. The advent of artificial intelligence, in particular, machine learning, and systems biology has opened the avenue for the efficient integration and interpretation of big datasets for discovering clinically translatable knowledge. In this narrative review, we discuss how big data integration and machine learning have been applied to translational IBD research. Approaches such as machine learning may enable patient stratification, prediction of disease progression and therapy responses for fine-tuning treatment options with positive impacts on cost, health and safety. We also outline the challenges and opportunities presented by machine learning and big data in clinical IBD research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2019-320065

Cites

124 of 124 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Precision medicine in IBD. Generation of big data from thousands of individuals, along with analytical advancements such as machine learning and systems biology, assists the application of precision medicine and therefore allows patient stratification for personalised therapeutic intervention and disease management strategies. MR, magnetic resonance; PCA, principal component analysis; RF, random forest.
Figure 1 Precision medicine in IBD. Generation of big data from thousands of individuals, along with analytical advancements such as machine learning and systems biology, assists the application of precision medicine and therefore allows patient stratification for personalised therapeutic intervention and disease management strategies. MR, magnetic resonance; PCA, principal component analysis; RF, random forest.CC BY · PubMed Central
Figure 2 Clinical management of IBD from the point of diagnosis to life-term monitoring and follow-up. Each stage of the disease management process can potentially be subjected to precision medicine-aided improvement of patient care to reduce the socioeconomic burden on patients, clinicians and the healthcare system.
Figure 2 Clinical management of IBD from the point of diagnosis to life-term monitoring and follow-up. Each stage of the disease management process can potentially be subjected to precision medicine-aided improvement of patient care to reduce the socioeconomic burden on patients, clinicians and the healthcare system.CC BY · PubMed Central
Figure 3 Academic initiatives with cohorts/biobanks in IBD. The numbers in each circle represent the approximate patient cohort size.
Figure 3 Academic initiatives with cohorts/biobanks in IBD. The numbers in each circle represent the approximate patient cohort size.CC BY · PubMed Central
Figure 4 Artificial intelligence in medical imaging. Graphical representation of a simple deep learning-based image segmentation approach to predict boundaries of inflamed areas. The top section of the figure represents the endoscopic image of colonic CD demonstrating the ‘cobblestone’ appearance and ulceration. Using a simple deep learning-based image segmentation method inflamed boundaries could be predicted: cobblestone in grey and inflamed ulcer in red. The bottom section of the figure illustrates a histopathology image of inflamed stenosis from ileal CD. A deep learning-based method could be used for image segmentation and predicting boundaries of inflamed areas: acute infiltration (ulcer) in red, muscolari mucosae thickening in blue and adipocytes hyperplasia in yellow. CD, Crohn’s disease.
Figure 4 Artificial intelligence in medical imaging. Graphical representation of a simple deep learning-based image segmentation approach to predict boundaries of inflamed areas. The top section of the figure represents the endoscopic image of colonic CD demonstrating the ‘cobblestone’ appearance and ulceration. Using a simple deep learning-based image segmentation method inflamed boundaries could be predicted: cobblestone in grey and inflamed ulcer in red. The bottom section of the figure illustrates a histopathology image of inflamed stenosis from ileal CD. A deep learning-based method could be used for image segmentation and predicting boundaries of inflamed areas: acute infiltration (ulcer) in red, muscolari mucosae thickening in blue and adipocytes hyperplasia in yellow. CD, Crohn’s disease.CC BY · PubMed Central
Figure 5 Opportunities and challenges in the use of machine learning and data integration to achieve improved and personalised healthcare in IBD. While challenges exist in generating good quality data in a standardised manner and at a volume deemed suitable for ensuring baseline performance of machine learning models, there remain difficulties in terms of the expertise needed to identify and employ appropriate tools for data integration and interpretation. However, with emerging advances in the data integration field, the incentives and opportunities to advance precision medicine with clinical implications are expected to drive integrative IBD research forward.
Figure 5 Opportunities and challenges in the use of machine learning and data integration to achieve improved and personalised healthcare in IBD. While challenges exist in generating good quality data in a standardised manner and at a volume deemed suitable for ensuring baseline performance of machine learning models, there remain difficulties in terms of the expertise needed to identify and employ appropriate tools for data integration and interpretation. However, with emerging advances in the data integration field, the incentives and opportunities to advance precision medicine with clinical implications are expected to drive integrative IBD research forward.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 124 references

Cited by

See all 248

Metadata

Authors
Seyed Tabib, N. S., Madgwick, M., Sudhakar, P., Verstockt, B., Korcsmaros, T., & Vermeire, S.
Affiliations
  • Department of Chronic Diseases, Metabolism and Ageing, TARGID, KU Leuven, Leuven, Belgium
  • Quadram Institute (GB)
  • KU Leuven (BE)
Corresponding author
Vermeire, Séverine
Venue
Gut
Publisher
BMJ
Published
2020-02-28
Volume
69
Issue
8
Pages
1520-1532
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W3007279380
Cited by
223
References
124
Citations by year
2026: 27 · 2025: 36 · 2024: 41 · 2023: 41 · 2022: 38 · 2021: 35 · 2020: 5
FWCI
4.25
Type
journal article
Language
en
Open access
Locations
  • Gut (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Lirias (KU Leuven) (submittedVersion, other-oa)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • Fonds Wetenschappelijk Onderzoek
  • H2020 European Research Council (ERC-2015-AdG, 694679)
  • Biotechnology and Biological Sciences Research Council (BB/CSP17270/1, BB/J004529/1, BB/P016774/1, BB/S50743X/1)
Topics
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
  • Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
Keywords
inflammatory bowel disease, big data, machine learning, artificial intelligence, systems biology, multi-omics integration, patient stratification, disease progression prediction, treatment response prediction, gut microbiota, translational research, clinical practice
MeSH terms
Gastrointestinal Microbiome, Machine Learning, Big Data, Humans, Image Interpretation, Computer-Assisted, Prognosis, Inflammatory Bowel Diseases, Risk Assessment, Gene Expression Profiling, Genomics, Proteomics, Metagenomics, Translational Research, Biomedical, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Big data in IBD: big progress for clinical practice. https://app.cochat.ai/papers/10.1136/gutjnl-2019-320065
The paper
Seyed Tabib, N. S., Madgwick, M., Sudhakar, P., Verstockt, B., Korcsmaros, T., & Vermeire, S. (2020). Big data in IBD: big progress for clinical practice. Gut. https://doi.org/10.1136/gutjnl-2019-320065

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.